Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090872
Company: RISING

Products on ANDA 090872

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SUMATRIPTAN AND NAPROXEN SODIUM	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500MG;EQ 85MG BASE	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 090872

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/04/2018	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/13/2024	SUPPL-2	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
03/25/2020	SUPPL-1	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.

Therapeutic Equivalents for ANDA 090872

SUMATRIPTAN AND NAPROXEN SODIUM

TABLET;ORAL; 500MG;EQ 85MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SUMATRIPTAN AND NAPROXEN SODIUM	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500MG;EQ 85MG BASE	TABLET;ORAL	Prescription	No	AB	207457	AUROBINDO PHARMA LTD
SUMATRIPTAN AND NAPROXEN SODIUM	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500MG;EQ 85MG BASE	TABLET;ORAL	Prescription	No	AB	090872	RISING
SUMATRIPTAN AND NAPROXEN SODIUM	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500MG;EQ 85MG BASE	TABLET;ORAL	Prescription	No	AB	202803	SUN PHARM
TREXIMET	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500MG;EQ 85MG BASE	TABLET;ORAL	Prescription	Yes	AB	021926	CURRAX